Compare Unilever plc (UL) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Unilever plc vs Zoetis Inc — how do they compare? Unilever plc trades at $62.45 (market cap $134.75B), while Zoetis Inc trades at $73.65 (market cap $30.29B). The key difference: Unilever plc is far larger — about 4.4× Zoetis Inc's market cap, and Unilever plc pays the higher dividend (3.4%). Which is the better fit depends on your goals.
| UL | ZTS | |
|---|---|---|
Market Cap | $134.75B | $30.29B |
Sector | Consumer Staples | Health |
52-Week High | $74.59 | $150.61 |
52-Week Low | $55.05 | $71.91 |
Enterprise Value | $160.73B | $37.86B |
Dividend Yield | 3.4% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Unilever (UL) trades at $63.54, down 1.03% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported revenue of $50.50 billion in 2025, with a net income margin of 18.32% and strong profitability metrics like ROE of 54.57%. Recent news highlights strategic partnerships in AI and a narrowed lawsuit with Ben & Jerry's, while Q2 2026 earnings showed 5.8% underlying sales growth, the strongest in a decade (Reuters, 2026-07-28).
Outlook is mixed: robust emerging market exposure and cost discipline support growth, but earnings misses and a net cash outflow of -$2.08 billion in 2025 pose risks. Analyst consensus is neutral with 51.36% hold ratings, reflecting cautious optimism amid execution challenges from portfolio simplification and competitive pressures.
Zoetis (ZTS) trades at $73.6, down 2.92% on the day, near its 52-week low amid bearish technical signals. The stock shows strong fundamentals with a P/E of 12, net margin of 27.69%, and consistent earnings beats, but faces headwinds from weak U.S. companion animal sales and reduced 2026 guidance. Recent news includes an FDA emergency use authorization for Simparica Trio and participation in healthcare conferences.
The outlook is mixed: valuation appears attractive with a consensus price target of $93.40, but near-term risks include competitive pressures and soft pet health demand. Long-term investors may find value in its profitability and market dominance, though volatility persists from sector challenges and investor sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
